Is Cognitive Orientation to daily Occupational Performance (CO-OP) more effective to achieve personal goals than conventional habilitation services for children with cerebral palsy or spina bifida?

ISRCTN ISRCTN12888658
DOI https://doi.org/10.1186/ISRCTN12888658
Submission date
04/02/2020
Registration date
12/02/2020
Last edited
10/06/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Research shows that people with Cerebral Palsy (CP) and Spina Bifida (SP) have difficulties governing their own lives due to executive dysfunctions (problem-solving, planning, initiation). Cognitive Orientation in Daily Occupational Performance (CO-OP) has been shown to enhance self-efficacy and executive functions in young adults with CP or SB through the enablement of self-chosen goals by learning of strategy-use and metacognitive thinking. This study aims to investigate the efficacy of CO-OP for children and adolescents with CP or SB compared to conventional habilitation services.

Who can participate?
Children and adolescents 9 to 16 year olds with cerebral palsy (with fairly good ability to use their hands) or spina bifida (with and without hydrocephalus) who:
1. Have experienced problems performing or organizing activities due to difficulties with initiative, planning, problem-solving and decision-making process
2. Go to school in compulsory school in the mainstream curriculum and communicate in Swedish
3. Are capable of formulating their own goals

What does the study involve?
The children and adolescents are randomly allocated to either a 10-week intervention with CO-OP or a waitlist group with ordinary habilitation services (control group). After 10 weeks the groups switch so the children and adolescents in the waitlist group start a COOP intervention. Four goals are identified by each child both in the intervention group and the control group (one remains untrained to study generalization and transfer to other environments or new situations). Investigations are done before and directly after the intervention and 3 months after.

What are the possible benefits and risks of participation?
The goal of this project is partly to be able to achieve the goals participants set themselves to cope with everyday activities by learning/improving their problem-solving ability and learning to use strategies. If any of these treatment effects are achieved, it is likely to mean increased independence in various activities, less dependence on relatives and assistants, and increased participation in everyday life as well as increased self-efficacy. The risks of participating in the project are very small. There is a small risk that those who participate may experience a feeling of failure, but the method is based on finding ways to achieve their goals, so the responsible occupational therapist will try to prevent this.

Where is the study run from?
This study is a multicenter study in four different regions in Sweden:
1. Regional Rehabilitation Centre for Children and Adolescents, Queen Silvia Children's Hospital
2. Habilitering & Hälsa, Region Stockholm
3. Habilitering & Hälsa Västra Götalandsregion
4. Habiliteringen Halland
5. Region Gävleborg, Barn- och ungdomshabilitering

When is the study starting and how long is it expected to run for?
April 2015 to June 2020

Who is funding the study?
1. Vastra Gotaland regional research fund
2. Norrbacka-Eugenia Foundation
3. Sahlgrenska University Hospital ALF
4. The Foundation Sunnerdahl Handikapp Fund
5. Josef och Linnea Carlssons Foundation
6. Regional research fund Habitation & Health, Vastra Gotalandsregionen
7. Folke Bernadotte Foundation
8. RBU Research Foundation

Who is the main contact?
Dr Marie Peny-Dahlstrand
marie.peny-dahlstrand@neuro.gu.se

Contact information

Dr Marie Peny-Dahlstrand
Scientific

Queen Silva Children's hospital, Regional Rehabilitation Centre
Box 210 62
Göteborg
SE 41804
Sweden

ORCiD logoORCID ID 0000-0002-6026-1136
Phone +46 (0)314347602
Email marie.peny-dahlstrand@neuro.gu.se
Dr Ann-Marie Öhrvall
Scientific

Karolinska Institutet, Departement for neurobiology, care sciences, and society
Division of Occupational Therapy
Fack 23200
Huddinge
SE-14183
Sweden

ORCiD logoORCID ID 0000-0002-3746-1295
Phone +46 (0)852483830
Email ann-marie.ohrvall@ki.se

Study information

Study designInterventional multicentre randomized cross over trial
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format. Please use the contact details to request a patient information sheet
Scientific titleIs Cognitive Orientation to daily Occupational Performance (CO-OP) more effective to achieve personal goals than conventional habilitation services for children with cerebral palsy or spina bifida: a randomised control trial
Study acronymCO-OP in children with CP or Spina Bifida
Study objectivesThe project is based on four hypotheses:
1. CO-OP is more effective than conventional habilitation services in order to reach self-identified activity goals
2. CO-OP intervention to a higher extent leads to the achievement of an untrained goal than conventional habilitation services (transfer effect)
3. With CO-OP intervention self-rated participation in society (estimated by the person himself) increases more than with conventional habilitation
4. CO-OP intervention increases executive ability to a greater extent than conventional habilitation
Ethics approval(s)Approved 19/05/2016, Regional Ethics Review Board in Gothenburg (Regionala etikprövningsnämnden i Göteborg, Box 401 405 30, Göteborg, Sweden; Tel: +46 (0)3178621), Dnr: 393-16, Ref. No. 393-16
Health condition(s) or problem(s) studiedCerebral palsy or spina bifida
InterventionThe children and adolescents will be allocated to either a 10-weeks intervention with CO-OP or waitlist group with ordinary habilitation services (control group). After 10 weeks the groups will switch so the children and adolescents in the waitlist group will start a COOP intervention. Four goals were identified by each child both in the intervention group and the control group (one remains untrained to study generalization and transfer to other environments or new situations). Investigations will be done before and directly after the intervention and 3 months after.
Intervention typeBehavioural
Primary outcome measure1. Self-rated goal attainment measured with Canadian Occupational Performance Measure (COPM) in both groups (both treatment and waitlist-control) at goalsetting before the treatment/control period, and directly after the period. COPM also used as follow up at 3 months after the treatment period for the treatment group
2. Objective goal attainment measured with Performance Quality Rating Scale (PQRS). This is an observational method, the participants' (when in the treatment group) performance of the four activities they choose as goals is video-recorded at the first treatment session and at the last and 3 months after the treatment period. These videos are rated by an independent rater according to the PQRS method. For the waitlist- control group, the performance of their four activities/goals is video recorded at pre-assessment before and after the waiting/control period and rated according to the PQRS method by an independent rater.
Secondary outcome measures1. Self-rated competence and value of everyday-activities are rated with The Child Occupational Self- Assessment-Swedish version (COSA-S) by the participants (in both groups) before, directly after and for treatment group 3 months post-intervention
2. Executive function is rated by proxy with Behavior Rating Inventory of Executive Function (BRIEF) and self-rated by participant > 11 years of age, before and directly after for both groups and at follow up after 3 months for the treatment group
3. Executive function is also measured with part of the Delis-Kaplan Executive Function System (D-KEFS, Trail Making Test, Tower test, Verbal Fluency Test) before and directly after for both groups and at follow up at 3 months for the treatment group
Overall study start date30/04/2015
Completion date13/06/2020

Eligibility

Participant type(s)Patient
Age groupChild
Lower age limit9 Years
Upper age limit16 Years
SexBoth
Target number of participants60
Total final enrolment46
Key inclusion criteriaChildren and adolescents with cerebral palsy (MACS I-III GMFCS I-IV) or spina bifida (with or without hydrocephalus), aged 9-16 years (in the year of enrolment) who have:
1. Experienced problems (self-perceived or experienced by parents) to perform or organize activities due to difficulties with initiative, planning, problem-solving and decision-making process
2. Goes to school in compulsory school in the mainstream curriculum and communicates in Swedish
3. Capability to formulate own goals
Key exclusion criteria1. Children who communicate with Augmentative and Alternative Communication (ACC) or are unable to communicate in Swedish
2. Going to compulsory school in special education for intellectual disability curriculum in time of enrolment
Date of first enrolment01/06/2017
Date of final enrolment30/08/2019

Locations

Countries of recruitment

  • Sweden

Study participating centres

Regional Rehabilitation Centre for Children and Adolescents, Queen Silvia Children's Hospital
Box 210 62
Göteborg
418 04
Sweden
Habilitering & Hälsa, Region Stockholm
Box 45436
Stockholm
104 31
Sweden
Habilitering & Hälsa Västra Götalandsregion
Ekelundsgatan 8
Göteborg
411 18
Sweden
Habiliteringen Halland
Hallands sjukhus
Halmstad
30185
Sweden
Region Gävleborg, Barn- och ungdomshabilitering
Folkparksvägen 5
Gävle
806 33
Sweden

Sponsor information

Queen Silvia Children's Hospital (Sweden)
Hospital/treatment centre

Regional Rehabilitation Centre for Children and Adolescents Box 210 62
Gothenburg
21062
Sweden

Phone +46 (0)700823125
Email marie.a.carlsson@vgregion.se
Website https://www2.sahlgrenska.se/en/SU/In-English/
ROR logo "ROR" https://ror.org/00yqpgp96
Habilitering och Hälsa VG-region
Hospital/treatment centre

Ekelundsgatan 8
Göteborg
411 18
Sweden

Phone +46 (0)700822239
Email arve.opheim@vgregion.se
Habiliteringen Halland
Hospital/treatment centre

Hallands sjukhus Halmstad
Halmstad
30185
Sweden

Phone +46 (0)70-556 51 44
Email Anna.Ingemansson@regionhalland.se
Habilitering & Hälsa
Hospital/treatment centre

Box 45436
Stockholm
104 31
Sweden

Phone +46 (0)8-123 350 01
Email joakim.lavesson@sll.se

Funders

Funder type

Research organisation

Vastra Gotaland regional research fund

No information available

Norrbacka-Eugeniastiftelsen
Private sector organisation / Trusts, charities, foundations (both public and private)
Alternative name(s)
Norrbacka-Eugenia Foundation
Location
Sweden
Sahlgrenska University Hospital ALF

No information available

The Foundation Sunnerdahl Handikapp Fund

No information available

Josef och Linnea Carlssons Foundation

No information available

Regional research fund Habitation & Health, Vastra Gotalandsregionen

No information available

Folke Bernadotte Foundation

No information available

RBU Research Foundation

No information available

Results and Publications

Intention to publish date30/06/2022
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planData is planned to be analysed during April-May 2020 and manuscript to be written and submitted in autumn 2020.
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Marie Peny-Dahlstrand (marie.peny-dahlstrand@vgregion.se).

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 04/03/2022 10/06/2022 Yes No

Editorial Notes

10/06/2022: The following changes have been made:
1. Publication reference added.
2. The scientific contact's details have been updated.
30/12/2021: The intention to publish date has been changed from 31/12/2021 to 30/06/2022.
07/07/2021: The intention to publish date has been changed from 01/07/2021 to 31/12/2021.
28/06/2021: The intention to publish date was changed from 31/12/2020 to 01/07/2021.
17/07/2020: The following changes were made to the trial record:
1. The overall end date was changed from 01/06/2020 to 13/06/2020.
2. The intention to publish date was changed from 31/10/2020 to 31/12/2020.
3. The total final enrolment was added.
12/02/2020: Trial's existence confirmed by Regional Ethics Review Board in Gothenburg.